September 26, 2025 ― HealthCare Institute of New Jersey (HINJ) President and CEO Chrissy Buteas issued a statement in support of life sciences companies’ role in healthcare in response to the Trump administration’s recommendations earlier this week that women limit Tylenol use during pregnancy, unless medically necessary.
“From rigorous R&D and clinical trials to comprehensive approval and regulatory processes, life sciences companies have long partnered with safety and efficacy agencies in the U.S. and globally to ensure that patient safety remains the cornerstone of advancing human health,” Buteas said. Read the full article here.